Abbott Laboratories Expands Nutrition Supply Chain in Pacific Asia

Abbott Laboratories has successfully finalized the takeover of Synlait’s Pōkeno operations, a critical development in the company's strategy to bolster its nutrition supply chain within the Pacific Asia region. This acquisition is expected to enhance Abbott's capacity to deliver nutritional products more efficiently across the region.

Synlait's Pōkeno facility, located in New Zealand, is a key asset in Abbott's portfolio, providing a strategic geographic advantage in terms of supply chain logistics. The facility is equipped to handle large-scale production, aligning with Abbott's goals to increase its market share in the nutritional product sector.

Abbott has been strategically expanding its operations globally, and the Pōkeno acquisition is a testament to its commitment to growing its nutritional business. The move is indicative of Abbott's efforts to meet increasing demand for nutrition products driven by changing dietary preferences and growing health awareness.

The deal was officially completed on January 25, 2026, marking a significant milestone for both Abbott and the local dairy industry in New Zealand. The acquisition aligns with Abbott's broader strategy to integrate more localized production capabilities to ensure product availability and reduce logistical costs.

With this acquisition, Abbott is poised to leverage Pōkeno's production capabilities to support its existing portfolio and potentially introduce new products tailored to the Pacific Asia market. This expansion reflects the company's broader objectives of securing a more robust position in the global nutrition market.